{"blog": [], "keywords": [{"value": "Shkreli, Martin (1983- )", "name": "persons", "rank": "1", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Turing Pharmaceuticals AG", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Generic Brands and Products", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "House Committee on Oversight and Government Reform", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "7", "is_major": "N"}, {"value": "Schiller, Howard B", "name": "persons", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/02/05/business/drug-prices-valeant-martin-shkreli-congress.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}, {"lastname": "HUETTEMAN", "firstname": "Emmarie", "role": "reported", "organization": "", "rank": 2}], "original": "By ANDREW POLLACK and EMMARIE HUETTEMAN", "contributor": ""}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "1292", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "pub_date": "2016-02-05T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Hearing on Drug Pricing Delivers Spectacle but Few Answers", "main": "Martin Shkreli Invokes the Fifth Amendment During Grilling by Congress"}, "print_page": "1", "snippet": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "_id": "56b325bd38f0d82036f0aa60", "slideshow_credits": null, "abstract": "Former Turing Pharmaceuticals chief executive Martin Shkreli refuses to answer questions during House Committee on Oversight and Government Reform hearing, exercising Fifth Amendment; Shkreli, who faces federal securities fraud charges, endures harsh criticism from lawmakers related to rising drug prices.  "}